Statin

Syndicate content

Doubts Raised About Drug Zetia In New Trial

Zetia has underperformed a vitamin according to the results of a new study. Zetia is taken by millions of Americans to lower LDL, when used in concert with statin drugs.

Get the full story...

Statin Drugs Up Survivability Against Flu

Statin drugs, primarily focused at reducing cholesterol, have been found to aid in something on the minds of many people. Yes, statin drugs help people make it through a flu infection.

Get the full story...

Statins May Protect Against Alzheimer's Disease

High cholesterol levels are considered to be a risk factor not only for cardiovascular disease including stroke, but also for the development of Alzheimer's disease. Therefore, many cholesterol lowering drugs, including statins, have been developed in recent years.

Get the full story...

Red Yeast Rice, a Natural Cholesterol-Lowering Substance?

For most people, cholesterol problems mean its time for statin drugs. But if you would prefer to avoid prescription drugs, there's been an unproven alternative: red yeast rice.

Get the full story...

Prescriptions Highlight Healthcare Inequalities

Statin prescription varies across geographic locations in Australia, demonstrating inequalities in healthcare.

Get the full story...

Statin warning for pregnant women

Pregnant women or those hoping to start or extend a family should avoid using the cholesterol-lowering drugs statins, say scientists.

Get the full story...

Simvastatin for hearts and minds?

Statins are not all equal when it comes to their potential to guard against dementia, according to a study published in the online open access journal BMC Medicine. Statins are cholesterol-lowering drugs used by those with heart disease. The new findings suggest that simvastatin is associated with a lower incidence of dementia and Parkinson’s disease.

Get the full story...

Retrospective Analysis of the Effect of Taking Statin

Researchers retrospectively analyzed the effect of taking peginterferon and ribavirin (PI+R, hepatitis C treatment options) and PI+R plus a statin to measure the sustained viral response (SVR, negative virus in blood six months after the end of treatment) rate in hepatitis C patients. A modified intent to treat approach was taken to compare the therapy alone to the therapy with addition of a statin.

Get the full story...